The Medicines Australia Code of Conduct defines standards for the promotion of prescription products in Australia, including aspects such as the conduct of promotional activities, the content of materials produced, and relationships between companies and healthcare professionals.
As a member of Medicines Australia, Ipsen Pty Ltd has undertaken to be open and transparent when we provide a reportable payment or transfer of value to a healthcare professional. Reportable payments or transfers of value are:
- Payments for the provision of services (but not limited to) such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant
- Airfares, accommodation and/or conference registration fees to attend medical education as part of those services.
Ipsen Pty Ltd prepares the report for publication in accordance with the current Medicines Australia Code of Conduct and Australia’s Privacy legislation.
The report is designed to be read on this website. It is also provided as a downloadable pdf file.
To comply with our privacy obligations, the report may be amended from time to time. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.
For further information about the details in the report, please go to https://medicinesaustralia.com.au/
From 30 August 2019, this information will now be held in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file.
For further information about the details in the report, or to search the database, please visit www.DisclosureAustralia.com.au
In addition to submitting its reports to Disclosure Australia, Ipsen Pty Ltd is publishing its report in CSV and PDF. Due to the nature of these reportable activities, which may include contracts spanning multiple reporting periods, there are some healthcare professionals who were contracted prior to the introduction of Medicines Australia’s database. This means these contracts did not include the now required statement informing of publication into a consolidated database. Therefore that data cannot be submitted to Disclosure Australia, and are instead included in the report published on this website.
If you are experiencing issues in viewing the CSV file in the correct format please select either the “Save” or “Save As” option and then open the file from its saved location.
Date of Preparation: March 2022 ALL-AU-000083
